ZEO launches physician masterclass ahead of Florida's SB-1768 stem cell therapy law

Zeo ScientifiX, Inc.

Florida's SB-1768, effective July 1, 2025, permits MDs and DOs to offer non-FDA-approved stem cell therapies under strict compliance.
ZEO's Masterclass on June 27, 2025, at NOVA Southeastern University educates physicians on SB-1768 compliance and clinical integration.
Company positions itself as trusted supplier of compliant stem cell products via its FDA-registered facility.
No financial guidance, revenue impact, or clinical trial results included in the announcement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.